• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非靶向代谢组学分析人血浆中的脂质标志物可揭示慢性阻塞性肺疾病和特发性肺纤维化的独特性。

Untargeted metabolomics of human plasma reveal lipid markers unique to chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis.

机构信息

Separation Science and Metabolomics Laboratory, Murdoch University, Murdoch, WA, Australia.

School of Biomedical Sciences, University of Western Australia, Nedlands, WA, Australia.

出版信息

Proteomics Clin Appl. 2021 May;15(2-3):e2000039. doi: 10.1002/prca.202000039. Epub 2021 Mar 18.

DOI:10.1002/prca.202000039
PMID:33580915
Abstract

Chronic obstructive pulmonary disease (COPD) is characterised by airway inflammation and progressive airflow limitation, whereas idiopathic pulmonary fibrosis (IPF) is characterised by a restrictive pattern due to fibrosis and impaired gas exchange. We undertook metabolomic analysis of blood samples in IPF, COPD and healthy controls (HC) to determine differences in circulating molecules and identify novel pathogenic pathways. An untargeted metabolomics using an ultra-high-performance liquid chromatography-quadrupole time-of-flight mass spectrometer (UHPLC-QTOF-MS) was performed to profile plasma of patients with COPD (n = 21), and IPF (n = 24) in comparison to plasma from healthy controls (HC; n = 20). The most significant features were identified using multiple database matching. One-way ANOVA and variable importance in projection (VIP) scores were also used to highlight metabolites that influence the specific disease groups. Non-polar metabolites such as fatty acids (FA) and membrane lipids were well resolved and a total of 4805 features were identified. The most prominent metabolite composition differences in lipid mediators identified at ∼2-3 fold higher in both diseases compared to HC were palmitoleic acid, oleic acid and linoleic acid; and dihydrotestosterone was lower in both diseases. We demonstrated that COPD and IPF were characterised by systemic changes in lipid constituents such as essential FA sampled from circulating plasma.

摘要

慢性阻塞性肺疾病(COPD)的特征是气道炎症和进行性气流受限,而特发性肺纤维化(IPF)则表现为纤维化和气体交换受损导致的限制模式。我们对 IPF、COPD 和健康对照组(HC)的血液样本进行了代谢组学分析,以确定循环分子的差异并确定新的致病途径。采用超高效液相色谱-四极杆飞行时间质谱联用仪(UHPLC-QTOF-MS)进行非靶向代谢组学分析,以分析 COPD(n=21)和 IPF(n=24)患者的血浆与健康对照组(HC;n=20)的血浆之间的差异。使用多个数据库匹配来鉴定最显著的特征。还使用单向方差分析和投影变量重要性(VIP)得分来突出影响特定疾病组的代谢物。非极性代谢物(如脂肪酸(FA)和膜脂质)得到了很好的解析,共鉴定出 4805 种特征。在两种疾病中脂质介质的代谢物组成差异最为明显,与 HC 相比,其丰度约高出 2-3 倍,分别是棕榈油酸、油酸和亚油酸;两种疾病中的二氢睾酮水平都较低。我们表明,COPD 和 IPF 以循环血浆中采样的必需 FA 等脂质成分的系统性变化为特征。

相似文献

1
Untargeted metabolomics of human plasma reveal lipid markers unique to chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis.非靶向代谢组学分析人血浆中的脂质标志物可揭示慢性阻塞性肺疾病和特发性肺纤维化的独特性。
Proteomics Clin Appl. 2021 May;15(2-3):e2000039. doi: 10.1002/prca.202000039. Epub 2021 Mar 18.
2
Identification of the lipid biomarkers from plasma in idiopathic pulmonary fibrosis by Lipidomics.采用脂质组学技术鉴定特发性肺纤维化患者血浆中的脂质生物标志物。
BMC Pulm Med. 2017 Dec 6;17(1):174. doi: 10.1186/s12890-017-0513-4.
3
There is detectable variation in the lipidomic profile between stable and progressive patients with idiopathic pulmonary fibrosis (IPF).特发性肺纤维化(IPF)稳定和进展患者的脂质组谱存在可检测的差异。
Respir Res. 2021 Apr 9;22(1):105. doi: 10.1186/s12931-021-01682-3.
4
Plasma Metabolomics and Lipidomics Reveal Perturbed Metabolites in Different Disease Stages of Chronic Obstructive Pulmonary Disease.血浆代谢组学和脂质组学揭示了慢性阻塞性肺疾病不同疾病阶段的代谢物紊乱。
Int J Chron Obstruct Pulmon Dis. 2020 Mar 9;15:553-565. doi: 10.2147/COPD.S229505. eCollection 2020.
5
Serum metabolic profiling identified a distinct metabolic signature in patients with idiopathic pulmonary fibrosis - a potential biomarker role for LysoPC.血清代谢组学分析鉴定出特发性肺纤维化患者的独特代谢特征 - LysoPC 可能作为生物标志物。
Respir Res. 2018 Jan 10;19(1):7. doi: 10.1186/s12931-018-0714-2.
6
Prognostic significance of surfactant protein A, surfactant protein D, Clara cell protein 16, S100 protein, trefoil factor 3, and prostatic secretory protein 94 in idiopathic pulmonary fibrosis, sarcoidosis, and chronic pulmonary obstructive disease.表面活性蛋白A、表面活性蛋白D、克拉拉细胞蛋白16、S100蛋白、三叶因子3和前列腺分泌蛋白94在特发性肺纤维化、结节病和慢性阻塞性肺疾病中的预后意义
Sarcoidosis Vasc Diffuse Lung Dis. 2016 Oct 7;33(3):224-234.
7
Study of the metabolomic relationship between lung cancer and chronic obstructive pulmonary disease based on direct infusion mass spectrometry.基于直接进样质谱的肺癌与慢性阻塞性肺疾病代谢组学关系研究。
Biochimie. 2019 Feb;157:111-122. doi: 10.1016/j.biochi.2018.11.007. Epub 2018 Nov 13.
8
Metabolomics in chronic lung diseases.代谢组学在慢性肺部疾病中的应用。
Respirology. 2020 Feb;25(2):139-148. doi: 10.1111/resp.13530. Epub 2019 Mar 25.
9
Endocannabinoid signalling/cannabinoid receptor 2 is involved in icariin-mediated protective effects against bleomycin-induced pulmonary fibrosis.内源性大麻素信号传导/大麻素受体 2 参与淫羊藿苷介导的对抗博来霉素诱导的肺纤维化的保护作用。
Phytomedicine. 2022 Aug;103:154187. doi: 10.1016/j.phymed.2022.154187. Epub 2022 May 21.
10
C-X-C motif chemokine 13 (CXCL13) is a prognostic biomarker of idiopathic pulmonary fibrosis.C-X-C基序趋化因子13(CXCL13)是特发性肺纤维化的一种预后生物标志物。
Am J Respir Crit Care Med. 2014 Apr 15;189(8):966-74. doi: 10.1164/rccm.201309-1592OC.

引用本文的文献

1
The Hypoxia-Retinoid Axis in Idiopathic Pulmonary Fibrosis: Multifaceted Etiology and Therapeutic Potential.特发性肺纤维化中的缺氧-视黄酸轴:多方面的病因及治疗潜力
Int J Mol Sci. 2025 May 31;26(11):5302. doi: 10.3390/ijms26115302.
2
Omic Risk Scores are Associated with COPD-related Traits Across Three Cohorts.全基因组关联研究风险评分与三个队列中慢性阻塞性肺疾病相关特征有关。
medRxiv. 2025 Jun 2:2025.06.01.25328699. doi: 10.1101/2025.06.01.25328699.
3
Innovative applications and future perspectives of chromatography-mass spectrometry in drug research.
色谱 - 质谱联用技术在药物研究中的创新应用及未来展望
Front Pharmacol. 2025 Mar 26;16:1529468. doi: 10.3389/fphar.2025.1529468. eCollection 2025.
4
Lipid metabolism reprogramming in chronic obstructive pulmonary disease.慢性阻塞性肺疾病中的脂质代谢重编程
Mol Med. 2025 Apr 7;31(1):129. doi: 10.1186/s10020-025-01191-9.
5
Lipolysis engages CD36 to promote ZBP1-mediated necroptosis-impairing lung regeneration in COPD.脂解通过 CD36 促进 ZBP1 介导热休克蛋白 70 诱导的细胞坏死性凋亡,从而损害 COPD 中的肺再生。
Cell Rep Med. 2024 Sep 17;5(9):101732. doi: 10.1016/j.xcrm.2024.101732. Epub 2024 Sep 9.
6
Pulmonary Fibrosis Diagnosis and Disease Progression Detected Via Hair Metabolome Analysis.通过毛发代谢组分析诊断肺纤维化和疾病进展。
Lung. 2024 Oct;202(5):581-593. doi: 10.1007/s00408-024-00712-3. Epub 2024 Jun 11.
7
Downregulation of HMGCS2 mediated AECIIs lipid metabolic alteration promotes pulmonary fibrosis by activating fibroblasts.HMGCS2的下调介导II型肺泡上皮细胞脂质代谢改变,通过激活成纤维细胞促进肺纤维化。
Respir Res. 2024 Apr 24;25(1):176. doi: 10.1186/s12931-024-02816-z.
8
Pulmonary Fibrosis and Diabetes Mellitus: Two coins with the same face.肺纤维化与糖尿病:同一枚硬币的两面。
Arch Intern Med Res. 2024;7(1):53-70. doi: 10.26502/aimr.0165. Epub 2024 Mar 16.
9
Circulating metabolic profile in idiopathic pulmonary fibrosis: data from the IPF-PRO Registry.特发性肺纤维化的循环代谢谱:来自IPF-PRO注册研究的数据。
Respir Res. 2024 Jan 25;25(1):58. doi: 10.1186/s12931-023-02644-7.
10
Metabolic pathways in immune senescence and inflammaging: Novel therapeutic strategy for chronic inflammatory lung diseases. An EAACI position paper from the Task Force for Immunopharmacology.免疫衰老和炎症老化中的代谢途径:慢性炎症性肺部疾病的新治疗策略。来自免疫药理学工作组的 EAACI 立场文件。
Allergy. 2024 May;79(5):1089-1122. doi: 10.1111/all.15977. Epub 2023 Dec 18.